OUR PRODUCTS

MOBILE APPS

GENERAL INFO

ALT

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Altimmune (ALT) Earnings Date & Reports

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases... Show more

Industry: #Miscellaneous Commercial Services

Get AI intraday signals

A.I. Advisor

published Earnings

ALT is expected to report earnings to rise 23.63% to -33 cents per share on November 11

Q3'25

Est.

$-0.33

Q2'25

Beat

by $0.04

Q1'25

Beat

by $0.12

Q4'24

Beat

by $0.01

Q3'24

Beat

by $0.04

The last earnings report on August 12 showed earnings per share of -27 cents, beating the estimate of -31 cents. With 3.04M shares outstanding, the current market capitalization sits at 320.37M.

View a ticker or compare two or three

Compare

ALT

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ALT
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ALT showed earnings on August 12, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Miscellaneous Commercial Services

Address

910 Clopper Road

Phone

+1 240 654-1450

Employees

Web

https://www.altimmune.com